Please login to the form below

Not currently logged in
Email:
Password:

Takeda regains Prostap from Wyeth

Takeda has signed an agreement with Wyeth to regain the product licence to market Prostap in the UK and Republic of Ireland

Takeda has signed an agreement with Wyeth to regain the product licence to market Prostap in the UK and Republic of Ireland.

Under the agreement, marketing authorisation for Prostap, a prostate cancer therapy, would return to the drug's developer, Takeda. The Japanese-owned company signed over the marketing authorisation for the product in the UK and Republic of Ireland to Wyeth in 1990.

Marketing for the entire Prostap product range in the UK and Republic of Ireland will revert to Takeda from July 1, 2009.

"The addition of Prostap will enrich our product portfolio, which currently consists of Amias, Actos and Competact, and is a logical development of our plan to develop a substantial franchise in the oncology market", commented Trevor Smith, Takeda UK's managing director.

Prostap is used for the treatment of prostate cancer, endometrisis and uterine fibroids. It is marketed in around 80 countries and is considered a gold standard therapy for prostate cancer.

26th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics